Impaired Cell Surface Expression of HLA-B Antigens on Mesenchymal Stem Cells and Muscle Cell Progenitors by Isa, Adiba et al.
Impaired Cell Surface Expression of HLA-B Antigens on
Mesenchymal Stem Cells and Muscle Cell Progenitors
Adiba Isa
1*, Jan O. Nehlin
1, Hardee J. Sabir
1, Tom E. Andersen
2, Michael Gaster
2, Moustapha Kassem
2,3,
Torben Barington
1
1Center for Stem Cell Treatment, Department of Clinical Immunology, Odense University Hospital, University of Southern Denmark, Odense, Denmark, 2Clinic for
Molecular Endocrinology (KMEB), Department of Endocrinology, Odense University Hospital and Medical Biotechnology Center, University of Southern Denmark, Odense,
Denmark, 3Stem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia
Abstract
HLA class-I expression is weak in embryonic stem cells but increases rapidly during lineage progression. It is unknown
whether all three classical HLA class-I antigens follow the same developmental program. In the present study, we
investigated allele-specific expression of HLA-A, -B, and -C at the mRNA and protein levels on human mesenchymal stem
cells from bone marrow and adipose tissue as well as striated muscle satellite cells and lymphocytes. Using multicolour flow
cytometry, we found high cell surface expression of HLA-A on all stem cells and PBMC examined. Surprisingly, HLA-B was
either undetectable or very weakly expressed on all stem cells protecting them from complement-dependent cytotoxicity
(CDC) using relevant human anti-B and anti-Cw sera. IFNc stimulation for 48–72 h was required to induce full HLA–B protein
expression. Quantitative real-time RT-PCR showed that IFNc induced a 9–42 fold increase of all six HLA-A,-B,-C gene
transcripts. Interestingly, prior to stimulation, gene transcripts for all but two alleles were present in similar amounts
suggesting that post-transcriptional mechanisms regulate the constitutive expression of HLA-A,-B, and -C. Locus-restricted
expression of HLA-A, -B and -C challenges our current understanding of the function of these molecules as regulators of
CD8
+ T-cell and NK-cell function and should lead to further inquiries into their expression on other cell types.
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Introduction
The highly polymorphic classical Major Histocompatibility
Complex (MHC) class I antigens consist of extracellular
membrane spanning heavy chains for HLA-A, -B, and -C, each
in complex with a non-MHC subunit, beta-2-microglobulin (b2m).
A major function of HLA molecules is presentation of intracellu-
larily produced peptides to T-cell receptors (TcR) of cytotoxic
CD8
+ T lymphocytes which leads to killing of infected cells. In
addition, HLA molecules act as ligands for the killer-cell
immunoglobulin-like receptors (KIRs) on natural killer cells (NK)
and NKT cells [1]. The Classical HLA class I can also act as
ligands by having their leader peptides presented on non-classical
HLA–E molecules to the CD94:NKG2A receptor on NK cells [2].
Furthermore, classical HLA class I molecules are ligands for
certain members of the leukocyte immunoglobulin-like receptor
(LILR/ILT/LIR) family, molecules with ill-defined regulatory
functions in the immune system [3]. While it is well known that the
three classical HLA class I loci and even alleles differ widely with
respect to their interaction with KIR on NK cells [4], much less is
known about differential effects of class I antigens on other aspects
of the immune function.
Allele-specific down-regulation of HLA class I is well-known in
cancer cells [5,6,7]. This is thought to result from genetic and
epigenetic instability combined with selection due to immune
recognition of tumour antigens and therefore may not be relevant
for normal cells. Isolated expression of HLA–C by extravillous
trophoblast is, however, well documented [8]. The fact that many
viruses are able to establish chronic infections (e.g. HIV, HPV, and
HBV [9,10,11]) and have developed mechanisms to down-
regulate HLA class I expression in a locus-specific way could
indicate differential functions of these molecules. Locus-specific
expression is, however, rarely addressed in normal cells outside the
haematopoietic system and almost all studies on HLA class I
expression after birth have used a single antibody (W6/32)
targeting simultaneously HLA–A, -B, -C and cross-reacting with
HLA-E and –F [12]. These studies are therefore unable to address
the differential expression of HLA class I loci [13]. Using such
antibodies, human embryonic stem cells have been shown to
express very low levels of HLA class I [14,15], while lineage-
committed stem cells like mesenchymal stem cells (MSC) have a
much higher expression similar to that of lymphocytes [16].
However, later on during differentiation, HLA class I expression
may be down-regulated or lost as suggested by the finding of
failure to constitutively express HLA class I in several terminally
differentiated cell types like neurons, hepatocytes, skeletal and
cardiac muscle cells [17].
Human MSC represent a subset of stromal stem cells present in
many adult tissues that have the potential to differentiate into
various cell types including cells of the mesodermal lineage such as
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expression of different surface markers and by the lack of
expression of the hematopoietic cell markers CD34, CD45 and
CD14 [18,19,20]. MSC efficiently suppress alloimmune responses
after transplantation due to their not fully understood immuno-
modulatory properties. They are known to express HLA class I
antigens as judged by staining with the W6/32 HLA-ABC
antibody, and expression of HLA class II molecules can be
induced upon stimulation [21].
Human satellite cells are mitotically quiescent muscle progen-
itors present in adult muscles. When activated, they proliferate as
muscle precursor cells which can fuse together and generate multi-
nuclear myotubes which are immature myofibers or fuse to
existing myofibers [22,23,24]. They have also shown the ability to
differentiate to adipocytes and osteocytes [25].
In the present study we have investigated HLA-A, -B and -C
expression using allele-specific antibodies and primer sets in MSC
and human satellite cells.
Results
Mesenchymal stem cells and human satellite cells
constitutively express high levels of HLA-A but not HLA-B
measured by allele-specific flow cytometry
All primary stem cell lines in this study were analyzed at
passages 2–4 and showed high expression of HLA class I judged by
direct staining with fluorochrome-conjugated anti-HLA-A,-B,-C
antibody (W6/32). Allele-specific HLA-A2, -A3, -B7, -B8, and -
B27 surface expression was measured on cells that were positive
for these antigens by genomic tissue typing. HLA-A2 and -A3 were
highly expressed ($+2) on all cell lines and PBMCs carrying the
corresponding genes, except one cell line that expressed somewhat
lower levels of HLA-A2 (+1) (Table 1 and Figure 1). Surprisingly,
cell-surface expression of all three analyzed HLA-B proteins were
either very low or absent on all 13 analyzed stem cell lines
(Figure 1A and B). We could not investigate the occurrence of
allele-specific HLA-Cw surface expression by flow cytometry due
to the lack of available allele-specific HLA-Cw antibodies. HLA-
DR was also analyzed by flow cytometry and in accordance to
previous data [16] it was not expressed on stem cells, although, it
could be induced on both MSC and human satellite cells by IFNc
stimulation (data not shown).
Induction and kinetics of HLA-B surface expression on
human stem cells by IFNc stimulation
We further explored whether the low-expressed HLA-B alleles
could be up-regulated on the cell-surface by stimulation with
rhIFNc. One cell line from each cell type, DD8, MSC-DF, MSC-
AT-661 and human satellite cell m233 and PBMC from donors 3
(Table 1 and Figure 2) and 4 (data not shown) were stimulated for
24, 48, and 72 h, respectively, with rhIFNc (25 ng/mL) and
analyzed by flow cytometry with fluorochrome-conjugated allele-
specific antibodies. The constitutive expression of HLA-A2 and -
A3 was already high on DD8 cells, however, after 72 h of IFNc
stimulation, a further ,10-fold increase was seen (Figure 2). HLA-
B7 was very low and HLA-B27 was virtually absent on DD8 cells,
but IFNc stimulation induced both alleles’ expression already after
24 h, and this up-regulation continued to 72 h. Additional four
days of stimulation did not increase the expression further (data
not shown).
Similar results were found for bone marrow-derived MSC-DF
cells (HLA-B7), adipose tissue-derived MSC-AT-661 (HLA-B8),
and human satellite cells m233 (HLA-B7) (Figure 2). In contrast to
the up-regulation of HLA class I on stem cells, HLA-A and -B
Table 1. Cells and cell lines of this study, their genomic types and semi-quantitative cell-surface expression of HLA class I.
Cell ID. Source Cell Type Genomic HLA Type Cell-surface expression
a
A B C A 2 A 3B 7B 8B 2 7
MSC-Tert clone DD8 Bone marrow Mesenchymal stem cell Tert
transfected
02, 03 07, 27 07, 02 3+ 2++ /2 +/2
MSC-DF Bone marrow Mesenchymal stem cell 02, 02 07, 44 05, 07 4++ /2
MSC TOB 11-02 Bone marrow Mesenchymal stem cell 02, 03 07, 40 03, 07 4+ NA -
MSC TOB 11-04 Bone marrow Mesenchymal stem cell 01, 03 08, 57 06, 07 3+ -
MSC-AT-661 Adipose tissue Mesenchymal stem cell 01, 23 08, 14 07, 08 4++ /2
m54 Muscle Human satellite cell 03, 25 18, 27 01, 12 NA 1+
m67 Muscle Human satellite cell 03, 29 07, 44 07, 16 3+ -
m226B Muscle Human satellite cell 02, 03 07, 51 07, 14 1+ NA -
m228 Muscle Human satellite cell 02, 02 27, 40 02, 03 3+ 1+
m231 Muscle Human satellite cell 02, 02 15, 27 02, 03 2+ -1 +
m233 Muscle Human satellite cell 03, 03 07, 14 05, 07 2+ -
m234 Muscle Human satellite cell 03, 29 07, 44 07, 16 3+ -
m235 Muscle Human satellite cell 03, 68 07, 39 05, 07 2+ 1+
PBMC 3 Peripheral blood Lymphocyte 02, 03 07, 27 07, 02 4+ 1+ 2+
PBMC 4 Peripheral blood Lymphocyte 03, 26 07, 27 07, 02 NA 2+ 2+
PBMC 7 Peripheral blood Lymphocyte 02, 26 08, 27 01, 07 4+ 4+ 2+
aSurface expression based on direct flow cytometry, only data from relevant combinations of antisera and genomic types are shown. NA= Not Analyzed, ‘‘2’’= the
specific mean fluorescence intensity (MFI) is #3 times higher than the MFI of the isotype control ‘‘+/2’’=,10 times, ‘‘1+’’= $10 times, ‘‘2+’’= $30 times, ‘‘3+’’= $50
times and ‘‘4+’’= $100 times.
doi:10.1371/journal.pone.0010900.t001
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no further up-regulation of HLA-A2, -B7 or -B27 could be
measured after 48 h of IFNc stimulation (Figure 2).
Down-regulation of HLA-B expression is re-established
after abrogation of IFNc stimulation
In order to see if IFNc-induced HLA-B expression was
reversible, we measured the kinetics of cell-surface HLA-A2, -
A3, -B7 and -B27 expression up to 96 h after removal of IFNc.
DD8 cells were stimulated with IFNc for 72 h, hereafter IFNc was
washed away and the kinetics of cell-surface expression of HLA-A
and -B was measured daily by flow cytometry. Already after 24 h,
down-regulation of HLA-A and -B was noticed. The cell-surface
expression of HLA-A and -B was decreased to the levels of the
non-induced conditions 72 h after removal of IFNc (data not
shown).
Determination of cell-surface HLA protein expression by
quantitative flow cytometry
For an accurate comparison and quantification of simultaneous
cell-surface expression of different HLA alleles on the same cell
line, we further measured allele-specific HLA-A2, -B7 and -B27
expression by indirect immunofluorescence staining and using a
standard curve based on beads conjugated with different known
numbers of murine IgG molecules and stained with the same
secondary antibody (see M&M). In un-stimulated cells, HLA-B7
and -B27 proteins were 17- and 40-fold less expressed,
respectively, compared to the expression of HLA-A2 protein and
HLA-B27 was 2.3 times less expressed than -B7. In comparison,
IFNc-stimulation increased HLA-A2 expression only 3-fold
(Figure 3 and Table 2) and at the peak of IFNc stimulation
(,72 h), HLA-B7 and -B27 surface expression had increased
about 50 and 92 times, respectively (Figure 3).
HLA-B molecules are not retained intracellularily
In order to investigate whether HLA-B protein is synthesized
within the cells but is prevented from reaching the cell surface in
the absence of IFNc, we performed intracellular staining to detect
HLA-A and -B proteins within DD8 cells. As a positive control for
intracellular staining, the cells were incubated with un-conjugated
anti-prolyl-4-hydroxylase antibodies, a protein normally present in
the endoplasmic reticulum, followed by incubation with a
Figure 1. Comparison of constitutive allele-specific HLA class I expression on stem cells and PBMC. Flow cytometry analysis of allele-
specific HLA class I expression. Histograms showing high expression of HLA-A2 and -A3 and a strongly downregulated HLA-B7, -B8 and -B27
expression on: (A) Four different primary human satellite cell lines, (B) Two bone marrow-derived primary MSC lines, (C) PBMCs from three different
individuals.
doi:10.1371/journal.pone.0010900.g001
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any intracellular HLA-B7 and -B27 proteins, however, a weak
HLA-A2 protein expression could be detected (data not shown).
Low constitutive expression of HLA-B and -C hamper
complement-dependent cytotoxicity
Using a routine serological complement-dependent cytotoxicity
(CDC) typing method [26] with allele-specific immune sera and
rabbit serum as the source of complement, we were able to
confirm the expression of HLA-A on all stem cells tested by their
massive killing (96%) with relevant anti-HLA-A anti-sera but not
by human AB serum (average 9%). In contrast, impaired killing
was observed for all HLA-B alleles tested (-B7, -B8, -B14 and -
B27); only about 28% of the MSC were recognized and killed with
anti-HLA-B anti-sera, which is not sufficient for typing as positive
(.50% killing) by standard criteria for this assay. Furthermore the
recognition and killing of MSC by anti-sera containing anti-HLA-
Cw (Cw2 and Cw7) antibodies were even lower (9%) i.e. the cells
were typed negative for HLA-Cw (Figure 4A).
IFNc-stimulation for 48 h was sufficient to allow positive test
results for HLA-B and -Cw. Under these circumstances, the killing
of MSC by anti-HLA-B and anti-HLA-Cw antibodies was 81%
and 26%, respectively (Figures 4).
Determination of quantitative allele-specific HLA-A, -B
and -C gene transcripts
High-resolution typing of HLA-A,-B,-C in DD8 cells was
performed and confirmed by cloning and sequencing the relevant
exons within the HLA loci. Based on the high resolution type, we
optimized allele-specific real time-PCR for measuring mRNA
expression of six HLA alleles: A*02:01:01, A*03:01:01, B*07:02:01
and B*27:02, C*02:02:02 and C*07:02 (Materials and methods).
We tested seven potential reference genes, and chose FBXL12
since it was only minimally influenced by IFNc stimulation (data
not shown). All real time-PCR-amplified cDNA fragments of MSC
line DD8 cell cultures were tested for purity by gel electrophoresis,
cloned and sequenced to confirm allele specificity.
In order to understand the mechanism(s) behind the low
constitutive HLA-B cell surface expression, we proceeded to
measure allele-specific gene transcripts in DD8 cells. Allele-specific
mRNA was detected for all six alleles and expressed as a geometric
mean of copy number of the target HLA allele/copy number of
the reference gene from three independent experiments. Prior to
IFNc stimulation and in striking contrast to the vast differences in
constitutive cell surface expression documented by flow cytometry
(Figure 2 and Table 2), transcripts of HLA-A*02, -A*03, -B*27
and -C*02 were expressed at similar levels (ratios: 1.6–2.0)
Figure 2. Kinetics of HLA-A and -B upon IFNc stimulation of MSC and human satellite cells. Overlay histograms showing expression of
HLA class I alleles before and after IFNc (25 ng/mL) stimulation. Kinetics (0 h, 24 h, 48 h and 72 h) is shown for different alleles, different MSC lines,
human satellite cells and PBMC.
doi:10.1371/journal.pone.0010900.g002
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only slightly lower than HLA-A*02 transcripts (0.9, p,0.01,
Student t test). In contrast, the constitutive (un-induced) expression
of HLA–C*07 was significantly higher than all other five HLA
class I alleles (7.4, p,0.01).
Stimulation with IFNc increased mRNA levels dramatically
already after 24 h culminating at 72 h (Figure 5A). HLA–B*27
increased 42-fold and ended up with the highest mRNA level of all
HLA class I alleles (,4-fold more transcripts than HLA-A*02)
while HLA-B*07 increased 30-fold and HLA-A*02 only about 9-
Figure 3. Kinetics of allele-specific HLA class I surface expression. Quantitative measurements of constitutive and up-regulated allele-specific
HLA class I protein expression pre- and post-IFNc stimulation of DD8 cells measured by indirect flow cytometry.
doi:10.1371/journal.pone.0010900.g003
Table 2. Primer sequences and quantitative allele-specific HLA-class I mRNA expression data on DD8 cells.
Primer
a Primer sequence (59-39) Fragment length (bp) mRNA copy no.
b Constitutive surface expression ABC
c
FBXL12-143F
d ACCTGACGCTCTACACGATGC 108 NA NA
FBXL12-251R GAGCCAGAGAACAGGTAGCCA
HLA A-minus2F GGATGGCCGTCATGGCGCC 1,065 NA NA
HLA A-1063 R CCTGGGCACTGTCACTGCTT
HLA B-minus40F-5 UTR CACGCACCCACCCGGACTCA 1143 NA
HLA-B-1091R-3 UTR TTTCAAGCTGTGAGAGACACATCA
HLA-Cw-minus49F-5UTR TAAAGTCCCCAGTCACCCACC 1,122 NA NA
HLA Cw-1073 R TCAGAGCCCTGGGCACTGTT
HLA-A020101-272F TGAAGGCCCACTCACAGACTC 111 8.9 204,370
HLA-A020101-383R CCCACGTCGCAGCCATACATT
HLA-A0301-508F AAGTGGGAGGCGGCCCATGA 128 10.7 NA
HLA-A0301-636R ATGTGTCTTGGGGGGGTCCGT
HLA-B0702-522F CCGTGAGGCGGAGCAGCG 99 30.1 12,076
HLA-B0702-621R GTCAGCGCGCTCCAGCTTG
HLA-B2702-232F GGGACCGGGAGACACAGATC 105 41.8 5,174
HLA-B2702-337R CGCTCTGGTTGTAGTAGCGGA
HLA-Cw020202-101F CCGCTGTGTCCCGGCCCA 117 18.6 NA
HLA-Cw020202-218F GCCCGCGGCTCCCCTCTT
HLA-Cw0702-972F TGGAGCTGTGGTCACCGCTA 95 5.4 NA
aThe numbers refer to the start of the primer relative to +1 ATG.
bmRNA Copy no./Reference gene mRNA copy no. measured in the same sample for each allele, see Materials and Methods.
cAntibody Binding Capacity (QifiKit), antibodies bound per cell from indirect flow cytometry.
dFBXL12 is the reference gene.
NA= Not Analyzed.
doi:10.1371/journal.pone.0010900.t002
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well with increases in surface expression of the corresponding
HLA alleles (A2, B7, B27) (Figure 5B).
The expression of HLA class I allele-specific mRNA was further
tested up to 96 h after removal of IFNc. In parallel with cell
surface expression, HLA class I allele-specific mRNA expression
Figure 4. Analysis of allele-specific HLA class I expression performed by complement-dependent microcytotoxicity assay. (A)
Histogram showing percentages of dead cells from three independent experiments. (B) Images showing CDC results for HLA-A2, -A3 and -B7 and -
B27 for IFNc-stimulated and non-stimulated DD8 cells. Green: living cells, red: dead cells.
doi:10.1371/journal.pone.0010900.g004
Figure 5. Kinetics of HLA class I gene transcripts upon IFNc stimulation and correlation between allele-specific surface protein
expression and mRNA expression. (A) Quantitative measurements of constitutive and up-regulated allele-specific HLA class I gene transcripts
pre- and post-IFNc stimulation by quantitative RT-PCR for DD8 cells. (B) Correlation between constitutive and up-regulated expression of HLA-A and -
B allelic gene transcripts and the capacity of antibody binding to the surface HLA class I allelic proteins by indirect flow cytometry staining for HLA-
A2, -B7 and -B27. HLA-B*07 showed the lowest constitutive mRNA expression while HLA-B27 showed the lowest constitutive protein expression.
doi:10.1371/journal.pone.0010900.g005
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reached at 72 h almost to the same levels as in un-stimulated
conditions (data not shown). Though this in itself strongly
suggested that copy numbers detected by qRT-PCR reflected full
length transcripts with the potential for translation, we wanted to
exclude that a predominant splice variant might interfere with
these results. We therefore performed long-range locus-specific
RT-PCRs comprising all exon-exon junctions for all three HLA
loci. Agarose gel electrophoresis revealed bands of the expected
sizes and these fragments were purified, cloned, sequenced and
found to contain all expected exons (1–8 for HLA-A and -C, 1-7
for HLA-B, data not shown). The results showed no indication of
the presence of a quantitatively significant splice variant within
any of the three HLA loci, neither in un-induced nor in stimulated
conditions. Some minor bands were seen though. A few of these
were purified and sequenced directly. Only PCR artefacts due to
mispriming were found.
Discussion
Human embryonic stem cells and trophoblasts have been shown
to express very low levels of HLA class I [14,15]. However, more
differentiated stem cells such as human mesenchymal stem cells
and human satellite cells express significant levels of HLA class I,
and have the ability to express HLA class II upon IFNc
stimulation [16,27]. Interestingly, MSC have been reported to
down-regulate HLA class I expression after differentiation to the
three different lineages, adipocytes, chondrocytes and osteocytes
and loose the ability to up-regulate their HLA class I upon IFNc
stimulation in the process [16]. This indicates a hitherto largely
unrecognized complexity in developmental regulation of HLA
expression and it is unknown if the three classical HLA class I
molecules follow the same developmental pattern or deviate from
each other.
In the present study we have investigated the constitutive allele-
specific expression of classical HLA class I on human MSC and
human satellite cells, both at the protein and mRNA levels. Both
cell types were strongly positive for the commonly used
monoclonal HLA-A,B,C antibody (clone W6/32). However, using
allele-specific antibodies targeting classical HLA class I molecules,
we found that there is a selective cell-surface expression of HLA-A
on these cells while HLA-B was highly down-regulated (Figure 1).
To the best of our knowledge, this is the first time a differential
locus-specific HLA class I expression is reported on normal human
cells and this contrasts to the approximately equal expression of
HLA-A, -B, and -C found on lymphocytes.
Furthermore, we investigated whether stem cells had the
capacity to up-regulate the surface expression of HLA-A and -B
alleles upon IFNc stimulation. Indeed, all stem cells up-regulated
their expression of HLA-A and -B with the highest fold increase
measured by quantitative flow cytometry during the first 24 h of
stimulation and peaking after 72 h. In contrast, PBMC did not
show any further up-regulation of HLA-A or -B (Figure 2). The
failure to express HLA-B on the surface of MSC was not due to
intracellular retention of protein, because no intracellular
expression of HLA-B protein could be detected in DD8 cells
during un-induced conditions. However, a weak intracellular
HLA-A2 expression was monitored in un-stimulated DD8 cells
(data not shown).
The constitutive expression of HLA-A and down-regulation of
HLA-B proteins were confirmed by complement-dependent
cytotoxicity tests (CDC). In accordance with flow cytometry data,
stem cells expressing high levels of HLA-A proteins were killed
when using human antisera containing HLA-A2 and -A3
antibodies (100% and 80% lysis, respectively). In contrast, stem
cells were relatively resistant to killing when using antisera
containing HLA-B and -C allele-specific antibodies, and only 4–
40% of the cells were killed (Figure 4A). This means that MSC
actually would have typed negative for the HLA-B types by
standard criteria for serological tissue typing. However, after 48 h
of stimulation with IFNc, MSC were shown to be more susceptible
to lysis compared to non-stimulated cells confirming the up-
regulation of HLA-B and suggesting a concurrent up-regulation of
HLA-C on these cells (Figure 4B).
We investigated whether the strong down-regulation of HLA-B
surface expression was due to the lack of HLA-B gene
transcription. Surprisingly, quantitative allele-specific HLA class
I RT-PCR data showed that gene transcripts were expressed at the
same levels in four out of six alleles (HLA-A*02, -A*03, -B*27 and
-C*02) in basal conditions, thus yielding no explanation for the
vast difference in surface expression. In comparison, HLA-B*07
and HLA–C*07 gene transcripts were expressed significantly
lower and higher, respectively (p,0.001, two-sample t test), but
even for HLA-B*07 the relative mRNA level (2-fold lower than
that of HLA-A*02) could not explain the low surface expression of
HLA-B7. Thus, we considered the possibility that this could be an
artefact due to the presence of different splice variants being
detected by RT-PCR but not able to generate functional proteins
as it has been shown previously in some cancer cell lines [28,29].
However, PCR amplification of full-length mRNA products ruled
out this possibility, since no significant splice variants of HLA class
I gene with potential of being amplified in our qRT-PCR were
detected.
HLA-A and -B have been reported to be regulated primarily at
the transcriptional level through promoter elements that are
conserved among the genes [30,31]. The induction of gene
transcription by IFNc has been shown to be mediated by the IFN-
stimulated response element (ISRE) which is located in the 59
promoter. Transcriptional control has also been reported in
trophoblasts for HLA-A and –B [8,16,31,32]. Recent data,
however, suggest that post-transcriptional regulation can also be
involved in the response of HLA-A to IFNc stimulation [33]. At
the mRNA level, all tested alleles in the present study showed
inducibility by IFNc, albeit at different levels, and the HLA-B
alleles studied were highly responsive to IFNc stimulation. HLA-
B*27 mRNA demonstrated the highest fold increase (x42) after
72 h of IFNc stimulation ending 4-fold higher than HLA-A*02 or
-A*03 mRNA’s (Figure 5A and Table 2). Previous studies have
shown that the HLA-B locus contains a much stronger ISRE than
the HLA-A locus which could be one of the reasons why HLA-B
genes are more inducible than HLA-A [34,35]. Accordingly, other
studies have shown that HLA-A genes are either very low or not
inducible by IFNc stimulation [34]. However we could measure a
3-fold up-regulation of HLA-A genes upon 72 h of IFNc
stimulation on DD8 cells. A proportional correlation could also
be measured between HLA class I allele-specific gene transcript
and cell-surface HLA class I antigen expression upon IFNc
stimulation (Figure 3) which confirms the presence of transcrip-
tional regulation during IFNc stimulation in accordance with
previously published data [36].
Competitive mRNA PCR data have previously been presented
regarding the differential mRNA locus-specific expression of HLA
class I mainly in cancer cell lines [30]. However, in the present
study we measured allele-specific HLA class I gene transcript
expression in DD8 cells. We have detected almost equal levels of
mRNA expression for all six but two alleles, despite the impaired
cell-surface expression of HLA-B and possibly HLA-C (based on
CDC data) antigens. Our current data here suggest the possible
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tion of HLA-B and possibly HLA-C surface antigens in the
absence of IFNc stimulation. The great discrepancy between the
constitutive locus-specific surface expression found amongst HLA-
A,-B and -C could possibly be explained by translation attenuation
by microRNA(s) specific for HLA-B (and possibly -C) alleles as it
has been shown for HLA-G expression [37].
Lack of constitutive HLA-B expression in normal cells
challenges current hypotheses in immunology. E.g. according to
the missing self hypothesis of NK-cell activation absence of HLA-B
expression should turn stem cells into targets of NK cell-mediated
killing in most HLA-Bw4 positive individuals who usually carry
this allotope on HLA-B (e.g. HLA-B27) and who usually carry
significant numbers of NK cells solely expressing the killer
inhibitory immunoglobulin-like receptor (KIR) 3DL1 which is
dependent on recognition of Bw4 for inhibition of killing [38,39].
If the down-regulation of HLA-B is a more general phenomenon
and not restricted to stem cells it might even be related to the
apparently different roles of classical HLA antigens in antimicro-
bial immunity that are currently emerging. For instance, immune
responses to HIV, EBV and Mycobacterium tuberculosis are often
dominated by T cells specific for a few epitopes which tend to be
presented by HLA-B rather than by HLA-A or –C [10,40,41].
HLA genotypes have also turned out to be important in
influencing outcomes of infections such as HIV and HCV [41].
Moreover, a clear association between HLA-B*27 genotype and
clearance of hepatitis C virus infection has been reported [42].
Increasing evidence indicates that there are two different subsets
within the CD4
+ and the CD8
+ T cells: effector T cells and
polyfunctional T cells. Polyfunctional CD8
+ T cells are more
capable of producing IL-2 and IFNc, and are associated with
stronger immune responses with efficient antiviral immunity than
effector T cells. Interestingly, studies have shown a tendency for
polyfunctional T cells to be specific for HLA-B restricted peptides
[43,44,45]. Furthermore, the tolerance mediating protein, pro-
grammed death-1 molecules (PD-1) is significantly up-regulated in
HLA-A restricted effector cells compared with HLA-B restricted
polyfunctional CD8+ T cells with low level expression of PD-1
[43].
An intriguing possibility is that lack of constitutive HLA-B
expression could be involved in the above mentioned mechanisms
by influencing the induction of peripheral tolerance towards HLA-
B restricted peptides.
In conclusion, our data here uniformly show that HLA-A is
highly expressed on human mesenchymal stem cells and human
satellite cells. Simultaneous expression of HLA-B is either very low
or absent on these cells. Further investigations will help to
elucidate the mechanism(s) that influence the differential expres-
sion of HLA-A and -B (and possibly -C) in stem cells and in
differentiated cells and their possible role in the regulation of
CD8
+ T-cells.
Materials and Methods
Cell lines and cell culture
Donors and cell lines were selected based on genomic HLA-A
and HLA-B types to assure that allele-specific antibodies were
available for at least one A and one B allele of each cell (Table 1).
Human mesenchymal stem cells derived from bone
marrow and adipose tissue
Primary human MSC derived from bone marrow (MSC-BM)
were established from bone marrow aspirates from four donors as
described previously [16]. Briefly, primary hMSC were cultured in
minimum essential medium (MEM) with low glucose (1 g/L)
containing 2 mM L-glutamine (Invitrogen), supplemented by 10%
fetal bovine serum (FBS, Invitrogen), 100 U/mL penicillin and
100 mg/mL streptomycin (Invitrogen). Adherent colonies were
detached by treatment with D-PBS based TryPLE Express
(Invitrogen) containing a trypsin-like enzyme and 1 mM EDTA
for 5 min at 37uC, and subsequently re-plated for continued
passage 1:2. Medium was changed twice weekly and cultures were
maintained at 37uC in a humidified atmosphere at 5% CO2.A
telomerase-immortalized subclone hMSC-Tert4 clone DD8 (DD8)
cells [46] were used while the remaining cell lines were used as
primary cultures at passages 2–4. Two MSC cell lines derived
from adipose tissue (MSC-AT) were obtained from subcutaneous
fat from two individuals undergoing liposuction at a plastic
surgical clinic, Odense, Denmark and established according to the
previously published method [47]. Briefly, the tissues containing
MSC-AT were washed several times in PBS [pH 7.4] Ca++,
Mg++ (Invitrogen) to remove red blood cells and digested with
200 U/mL collagenase I (Sigma) in 3 mM CaCl2 (Sigma) for
60 min at 37uC. Subsequently, the suspensions were centrifuged
and pellets were washed once in aMEM (Invitrogen). Prior to
culture, the cells were filtered through a 300 mm nylon mesh to
remove fibrous tissue and cells were seeded at passage 0 (5–
7610
3 cells/cm
2). MSC properties were confirmed by flow
cytometry showing high expression of CD44, CD73, CD105,
CD166 and CD146, and no expression of CD34, and by the
capacity to differentiate into the three lineages in vitro: osteoblasts,
adipocytes, and chondrocytes [25].
Human satellite cell derived from muscle biopsies
Human satellite cell cultures were established from quadriceps
femoris muscle biopsies as previously described [48,49]. The stem
cells used in this study were stimulated by recombinant human
interferon gamma (rhIFNc) (Invitrogen) at a final concentration of
25 ng/mL since higher concentrations of rhIFNc did not result in
higher HLA up-regulation (data not shown).
Flow cytometry
Cells were trypsinized and washed twice with PBE (PBS
containing 2 mM EDTA (Ambion) and 5% fetal bovine serum
(FBS, Invitrogen)). The cells were stained with the appropriate
monoclonal antibodies (mAb’s) (see detailed information in
supporting Table S1), incubated for 20 min in dark on ice. The
cells were washed twice with PBE and fixed in 1% formaldehyde
in PBS (Bie Berntsen). Intracellular staining was performed with
BD fixation and cytoperm kit (BD Biosciences), according to the
manufacturer’s instructions. When measuring the presence of
intracellular HLA-A2, -B7 and -B27 proteins, the extracellular
HLA-A2 proteins were blocked with purified un-conjugated anti-
HLA-A2 antibodies, followed by staining with fluorochrome-
conjugated antibodies against HLA-A2, HLA-B7 and HLA-B27
for 20 min, in the dark on ice followed by 2 washes (with 1x BD
Perm/Wash
TM buffer) and fixation (Table S1). Quantification of
surface bound allele specific HLA molecules on each cell was
performed by QifiKit (Dako) using indirect immunofluorescence
staining. Primary un-conjugated antibodies against HLA-A2
(0.05 mg/mL), HLA-B7 (0.1 mg/mL) and HLA-B27 (10 mL)
were carefully titrated. Cells were incubated with the antibodies
30 min on ice followed by 2 washes with PBE. Thereafter, cells
were stained with the same FITC-conjugated polyclonal rabbit
anti-mouse antibodies as above. The quantity of the bound
primary antibodies was estimated using a standard curve for beads
with different known numbers of murine IgG molecules stained
with the same secondary antibody.
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as positive controls (Table 1). Each staining was performed in
parallel with Ig isotype controls, which in all cases were shown to
be negative except in the FITC channel in which all stem cells
showed low-intensity autofluorescence. Blockade of Fc receptors
by incubation of the cells with mouse serum did not affect the
signals of the isotype controls (data not shown). Cell acquisition
was performed with CyAn-ADP (Beckman Coulter) using Summit
4.3.1 software (Dako). Immediately, prior to cell acquisition,
150 mL of TryPLE express (Invitrogen) was added to the cell
suspension to avoid clotting in the CyAn. The flow cytometer was
standardized by using positive and negative controls and
calibration beads each time to reduce day-to-day variation.
Complement-dependent microcytotoxicity assay (CDC)
HLA-A, -B and -C surface expression and the lack of
expression were confirmed by using the traditional CDC assay,
using allo-antisera in Terasaki trays, as previously described with
some minor modifications [26]. Briefly, the cells were re-
suspended in 100 mL of Terasaki and Park medium (including
10% heat inactivated human AB serum). One mL of the cells was
plated and incubated for 30 min at room temperature (rt) with
equal amounts of allo-antisera. Subsequently 2 mLo fr a b b i t
complement mixture (1 mL freshly used complement, supple-
mented with 15 mL mixture of 0.03% acridine orange and 0.1%
ethidium bromide (Ampliqon)) was added to the cells, mixed and
incubated at rt in the dark for 60 min. As positive control we
stained the cells either with a pool of HLA-A antibodies or
PBMCs expressing the corresponding HLA alleles. As negative,
we incubate the cells with human AB+ serum in each staining.
The cytotoxicity rate was determined by quantitative analysis
using an inverted fluorescence microscope DM-IRB with a DAPI
filter (Leica). All samples were run in duplicates in 3 experiments
and were scored by randomized and blinded counting; at least
200 cells per well were counted. Cells positive for a specific allele
stained red, since the cells were lysed and EtBr was incorporated
in the nucleus. In contrast, cells which did not express the
corresponding HLA allele had an intact cell membrane and
stained green under the microscope.
HLA typing
Genomic DNA was purified from cells with the QiaAmp DNA
Mini-kit (Qiagen). Low-resolution HLA class I types were
determined using the LabType SSO (Sequence-specific oligonu-
cleotide probes) typing test (One Lambda) using a Luminex 100 IS
(Luminex Corp.) flow analyzer as recommended by the manufac-
turers (Table 1).
RNA isolation and cDNA synthesis
Total RNA was isolated from DD8 cells using the RNeasy Plus
mini RNA purification kit (Qiagen) and quantified by NanoDrop
spectrophotometry (Thermo Fisher Scientific). The cDNA was
synthesized using the RevertAid H Minus first strand cDNA
synthesis kit with random hexamer primers (Fermentas).
High resolution typing and full-length cloning of
allele-specific HLA class I genes and transcripts
PCR primer pairs were designed to amplify HLA-A, -B, -C
locus-specific fragments and -A*02, -A*03, -B*07, -B*27, -C*02, -
C*07 allele-containing cDNA, synthesized from 50-100 ng of
total RNA. PCR was performed either using AmpliTaq Gold
DNA polymerase (Applied Biosystems) or Herculase II Fusion
DNA polymerase with dNTPs combo kit (Stratagene). The
reactions were incubated in a Mastercycler (Eppendorf) 5–12 min
at 95uC, followed by 40 cycles (30–60 sec at 95uC, 30–60 sec at
66uC and 1.5–2 min at 72uC) and one final 10 min step at 72uC.
The DNA was purified using the GFX PCR DNA and gel band
purification kit (GE Healthcare) and sequenced using the same
primers as used during PCR-amplification, using an ABI PRISM
3130xl genetic analyzer (Applied Biosystems) according to the
published method [50]. When direct fragment sequencing was
not possible, cDNA fragments encoding HLA alleles were ligated
into a pJET1.2/blunt cloning vector using the CloneJet PCR
cloning kit (Fermentas) and transformed into E. coli strain TOP10
(Stratagene). Single colonies were grown to isolate plasmid DNA
using a plasmid purification Mini-kit (Qiagen) followed by
sequencing.
The full-length sequences of DD8 HLA alleles can be retrieved
from the IMGT/HLA database at: http://www.ebi.ac.uk/imgt/
hla/allele.html [51].
Allele-specific HLA class I quantitative RT-PCR
Primers for real-time PCR were designed to amplify fragments
corresponding to the six HLA-A, -B, -C alleles of DD8 cells. Only
primers which generated a single fragment of the predicted size
judged by agarose gel electrophoresis and melting curve analyses
were considered. Furthermore, allele specificities were confirmed
by direct sequencing of the products. Seven different reference
genes were tested; amongst them FBXL12 was chosen since its
expression showed similar CT values to un-stimulated HLA-A
transcripts and low responsiveness to rhIFNc [52]. The PCR
reaction contained SyBr green PCR master mix (Applied
Biosystems), 0.25 mM of each primer (see Table 2) and cDNA
(corresponding to 25 ng of total RNA). Quantitative PCR was
performed in a 7300 Real-Time PCR system (Applied Biosystems).
The reactions were first incubated 2 min at 50uC, and 10 min at
95uC, followed by 40 cycles (15 sec at 95uC, 30 sec at 66uC and
1 min at 72uC) and 10 min at 72uC, and a final DNA dissociation
step. CT-value standard curves for each allele and reference gene
were included on all plates consisting of serial 10-fold dilutions (six
different dilutions) of pCR2.1-TOPO plasmids containing the
PCR amplified fragments. The plasmids were diluted in ultrapure
water containing 10 ng/mL yeast tRNA (Invitrogen) and 5 mL
were added to the PCR mix generating final concentrations
ranging from 2610
22 22610
27 ng/mL. Amplification efficiencies
were calculated by the method of Pfaffl [53] and only primer
combinations with an efficiency exceeding 1.96 per cycle (actual
range: 1.92–2) were accepted. For each sample, the cDNA copy
number was calculated from the standard curve and divided by the
copy number of the reference gene.
Primer design and software
Databases containing all available HLA-A, -B and -C allele
sequences obtained from release 2.24.0 (2009) of the IMGT/HLA
database (http://www.ebi.ac.uk/imgt/hla/) were compiled to
allow for the matching of input sequences to HLA subtypes
[51]. An HLA-specific primer-design algorithm was conceived to
facilitate the search for forward and reverse HLA allele-specific
primers that would satisfy a number of requirements such as a 39
base difference, 21-mer length, melting temperature of 66uC,
amplified fragment length of 70-120 bp and no cross-reactivity
with other alleles in the HLA database. HLA-ABC allele-specific
sequences obtained for DD8 cells were aligned using the AlignX
algorithm of VectorNTI Advance version 10 software (Invitrogen).
We also designed HLA allele-specific primers using OLIGO 6.0
(Molecular Biology Insights).
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